CANF

Can-Fite Biopharma Ltd ADR

$4.93

+0.34 (+7.41%)

Analyst Overview

Target Price:

Date: 27.02.2026

$3.50

(-29.01%)

Strong Buy: 0

Buy: 1

Hold: 1

Sell: 0

Strong Sell: 0

Description:

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutics for the treatment of cancer, liver and inflammatory diseases, COVID-19, and erectile dysfunction. The company is headquartered in Petah-Tikva, Israel.

Exchange:

NYSE MKT

Country:

USA

Sector:

HEALTHCARE

Industry:

BIOTECHNOLOGY

Address:

26 BEN GURION STREET, RAMAT GAN, ISRAEL, 5257346

Fiscal year end:

December

Market capitalization:

$15.2 Million

EBITDA:

-$8.91 Million

PERatio:

0.0

EPS:

0.0

Dividend per share:

$0.00

Dividend yield:

0.0%

Beta:

0.042

Dividends for 10 years

Income Statements for 10 years

Earnings calender

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:

$1,000

How much will you earn in 14 years:

-100%

How much will you get:

Prices dates:

06-11-2012: $16,072.68 and 30-01-2026: $4.01